TGFBI and lip and oral cavity carcinoma: Our results not only disclose novel targets for oral cancer control, but also provide feasible applications, e.g, a single immunohistochemical assay of TGFBI from treatment naïve or recurred tumor biopsies, to assist clinical decision-making.